Use of E-health Based Exercise Intervention After COVID-19
NCT ID: NCT05770505
Last Updated: 2026-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2023-04-17
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
E-health Interventions to Promote Physical Activity Among Inactive Adults
NCT04526444
Improving Health Status in COVID-19 Long-Hauler
NCT06679218
"Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention"
NCT04400305
Intervention Program Among University Student to Promote Physical Activity and Reduce the Sedentary Time
NCT05019482
Physical Activity Coaching in Patients with Post-COVID-19
NCT06165978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supervised exercise
Exercise training using an e-health tool
Experimental: Exercise training will be guided by using the e-health tool MIA Health, with the possibility for digital communication between the participants and study personnel The participants will receive wearables that record heart rate. Participants will be encouraged to achieve 100 Activity Quotient (AQ) equivalents per week Control: No follow-up
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise training using an e-health tool
Experimental: Exercise training will be guided by using the e-health tool MIA Health, with the possibility for digital communication between the participants and study personnel The participants will receive wearables that record heart rate. Participants will be encouraged to achieve 100 Activity Quotient (AQ) equivalents per week Control: No follow-up
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People who struggle to be physically active enough as a result of corona disease
* People who experience reduced physical fitness as a result of corona disease
Exclusion Criteria
* uncontrolled hypertension (high blood pressure) (over 200/110).
* symptomatic valve failure, hypertrophic cardiomyopathy, unstable angina, pulmonary
* hypertension, heart failure and/or severe rhythm disturbances
* cancer that makes participation impossible or exercise contraindicated. Considered individually in consultation with the attending physician.
* chronic contagious infectious diseases.
* Participates in other studies that are not compatible with participation in this project
* Post-exertional symptom exacerbation (PESE)/post-exertional malaise (PEM)/post-exertional neuroimmune exhaustion (PENE).
18 Years
59 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dorthe Stensvold Stensvold
Role: PRINCIPAL_INVESTIGATOR
Dorthe Stensvold, Professor, NTNU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norwegian University of Science and Technology, Faculty of medicine, Department of circulation and medical imaging,
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
479316
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.